ScholarIQanswers from OpenAlex & ORCID
Nina Shah
ResearcherPublications, citations & collaboration network
Nina Shah is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nina Shah have?
ScholarIQindexed works
Nina Shah has 527 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nina Shah have?
ScholarIQcitation count
Nina Shah has 13,041 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nina Shah?
ScholarIQh-index
Nina Shah has an h-index of 53 in OpenAlex.
What is the i10-index of Nina Shah?
ScholarIQi10-index
Nina Shah has an i10-index of 195 in OpenAlex.
What is the ORCID of Nina Shah?
ScholarIQorcid
The ORCID for Nina Shah is on the source record.
What is the OpenAlex record for Nina Shah?
ScholarIQopenalex
The OpenAlex for Nina Shah is on the source record.
What are the most-cited papers on Nina Shah?
ScholarIQmost cited works
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
Peter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J. Costa, Larry D. Anderson, Nitya Nathwani, Nina Shah, Yvonne A. Efebera, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Séan Murphy, Yana Lutska, Huiling Pei, Jon Ukropec, Jessica Vermeulen, Carla de Boer, Daniela Hoehn, Thomas S. Lin, Paul G. Richardson
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
Nina Shah, Ajai Chari, Emma Scott, Khalid Mezzi, Saad Z. Usmani
Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture
Marcos de Lima, Ian McNiece, Simon N. Robinson, Mark F. Munsell, Mary Eapen, Mary M. Horowitz, Amin M. Alousi, Rima M. Saliba, John D. McMannis, Indreshpal Kaur, Partow Kebriaei, Simrit Parmar, Uday Popat, Chitra Hosing, Richard E. Champlin, Catherine M. Bollard, Jeffrey J. Molldrem, Roy B. Jones, Yago Nieto, Börje S. Andersson, Nina Shah, Betül Oran, Laurence J.N. Cooper, Laura L. Worth, Muzaffar H. Qazilbash, Martin Körbling, Gabriela Rondón, Stefan O. Ciurea, Doyle Bosque, I. Maewal, Paul J. Simmons, Elizabeth J. Shpall
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A. Stadtmauer, Marcelo C. Pasquini, Beth Blackwell, Parameswaran Hari, Asad Bashey, Steven M. Devine, Yvonne A. Efebera, S. Ganguly, Cristina Gasparetto, Nancy L. Geller, Mary M. Horowitz, John Koreth, Kristin Knust, Heather Landau, Claudio G. Brunstein, Philip L. McCarthy, Courtney Nelson, Muzaffar H. Qazilbash, Nina Shah, David H. Vesole, Ravi Vij, Dan T. Vogl, Sergio Giralt, George Somlo, Amrita Krishnan